Rhema Vaithianathan

Summary

Affiliation: University of Auckland
Country: New Zealand

Publications

  1. pmc The cost of child health inequalities in Aotearoa New Zealand: a preliminary scoping study
    Clair Mills
    Te Kupenga Hauora Maori, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    BMC Public Health 12:384. 2012
  2. doi request reprint Children in the public benefit system at risk of maltreatment: identification via predictive modeling
    Rhema Vaithianathan
    Centre for Applied Research in Economics, Department of Economics, University of Auckland, New Zealand
    Am J Prev Med 45:354-9. 2013
  3. ncbi request reprint Supply-side cost sharing when patients and doctors collude
    Rhema Vaithianathan
    Department of Economics, University of Auckland, PBN 92019, Auckland, New Zealand
    J Health Econ 22:763-80. 2003
  4. ncbi request reprint Health insurance and imperfect competition in the health care market
    Rhema Vaithianathan
    University of Auckland, Department of Economics, PBN 92019, Auckland, New Zealand
    J Health Econ 25:1193-202. 2006
  5. ncbi request reprint Better the devil you know than the doctor you don't: is advertising drugs to doctors more harmful than advertising to patients?
    Rhema Vaithianathan
    Department of Economics, University of Auckland, Auckland, New Zealand
    J Health Serv Res Policy 11:235-9. 2006
  6. doi request reprint Iatrogenic effects of COX-2 inhibitors in the US population: findings from the Medical Expenditure Panel Survey
    Rhema Vaithianathan
    Department of Economics, University of Auckland, Auckland, New Zealand
    Drug Saf 32:335-43. 2009
  7. ncbi request reprint Building on myths: an economist's response to the Ministerial Review Group Report on the health system
    Rhema Vaithianathan
    Department of Economics, University of Auckland, Auckland, New Zealand
    N Z Med J 123:79-83. 2010
  8. doi request reprint The NHS as an insurer
    Rhema Vaithianathan
    University of Auckland, Auckland, New Zealand
    J Health Serv Res Policy 15:171-3. 2010

Collaborators

Detail Information

Publications8

  1. pmc The cost of child health inequalities in Aotearoa New Zealand: a preliminary scoping study
    Clair Mills
    Te Kupenga Hauora Maori, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    BMC Public Health 12:384. 2012
    ..This study aimed to develop a preliminary estimate of the economic cost of health inequities between Māori (indigenous) and non-Māori children in New Zealand...
  2. doi request reprint Children in the public benefit system at risk of maltreatment: identification via predictive modeling
    Rhema Vaithianathan
    Centre for Applied Research in Economics, Department of Economics, University of Auckland, New Zealand
    Am J Prev Med 45:354-9. 2013
    ..Although a PRM cannot replace more-comprehensive clinical assessments of abuse and neglect risk, this approach provides a simple and cost-effective method of targeting early prevention services. ..
  3. ncbi request reprint Supply-side cost sharing when patients and doctors collude
    Rhema Vaithianathan
    Department of Economics, University of Auckland, PBN 92019, Auckland, New Zealand
    J Health Econ 22:763-80. 2003
    ..If patients have a high willingness to pay or are informed, then allowing collusion may be preferred...
  4. ncbi request reprint Health insurance and imperfect competition in the health care market
    Rhema Vaithianathan
    University of Auckland, Department of Economics, PBN 92019, Auckland, New Zealand
    J Health Econ 25:1193-202. 2006
    ..The results suggest a beneficial role for Government intervention, either in the insurance or the health care market...
  5. ncbi request reprint Better the devil you know than the doctor you don't: is advertising drugs to doctors more harmful than advertising to patients?
    Rhema Vaithianathan
    Department of Economics, University of Auckland, Auckland, New Zealand
    J Health Serv Res Policy 11:235-9. 2006
    ..This is particularly apt, given the calls for similar transparency rules to address the potential conflict of interest between drug companies and researchers...
  6. doi request reprint Iatrogenic effects of COX-2 inhibitors in the US population: findings from the Medical Expenditure Panel Survey
    Rhema Vaithianathan
    Department of Economics, University of Auckland, Auckland, New Zealand
    Drug Saf 32:335-43. 2009
    ..Selective cyclo-oxygenase 2 inhibitors ('coxibs') have been demonstrated to increase cardiovascular risk, but the cumulative burden of adverse effects in the US population is uncertain...
  7. ncbi request reprint Building on myths: an economist's response to the Ministerial Review Group Report on the health system
    Rhema Vaithianathan
    Department of Economics, University of Auckland, Auckland, New Zealand
    N Z Med J 123:79-83. 2010
    ..Restructuring is an extremely expensive exercise--and should only be done when there is a compelling logic to the new structure...
  8. doi request reprint The NHS as an insurer
    Rhema Vaithianathan
    University of Auckland, Auckland, New Zealand
    J Health Serv Res Policy 15:171-3. 2010
    ..Insurance value should be a guiding principle for NHS decision-makers...